115 GROUP MANAGEMENT REPORT COMPANY ON THE MOVE REPORT OF THE BOARD OF MANAGEMENT CORPORATE RESPONSIBILITY CONSOLIDATED FINANCIAL STATEMENTS CASH FLOW STATEMENT Notes 2013 2012 million million Earnings before taxes 117.7 114.2 Financial result (net) 6.8 38.1 36.7 Depreciation/amortisation/impairment and gains/losses on disposal of assets 6.5 121.0 139.9 Non-cash valuations of financial derivatives 7.22 0.0 ­0.1 276.8 290.7 Change in net current assets Change in inventories 7.8 ­3.0 ­3.0 Change in accounts receivable 7.9 ­2.5 ­54.7 Change in other financial assets and other assets 7.10 seq. 3.5 10.5 Change in accounts payable 7.18 22.9 3.4 Change in other net liabilities/Other non-cash transactions 7.19 seq. ­23.9 ­39.7 Change in provisions 7.16 seq. ­1.6 ­1.3 Income taxes paid 6.9 ­22.0 ­23.2 Interest paid ­39.8 ­43.6 Cash generated from operating activities 210.4 139.1 Investments in property, plant and equipment and in intangible assets 7.2 ­165.3 ­193.1 Government grants received to finance investments in property, plant and equipment and in intangible assets 58.6 53.2 Acquisition of subsidiaries, net of cash acquired 4 ­1.5 ­54.8 Sale proceeds from disposal of assets 4.6 7.7 Interest received 6.8 2.4 6.7 Cash used in investing activities ­101.2 ­180.3 Proceeds from issuing long-term debt 7.15 58.7 0.0 Repayment of financial liabilities 7.15 ­233.2 ­113.2 Dividend payments to shareholders of RHÖN-KLINIKUM AG 7.14 ­34.6 ­62.2 Contributions from non-controlling interests in equity/payments to non-control- ling interests in equity 7.14 ­3.2 ­3.4 Cash used in financing activities ­212.3 ­178.8 Change in cash and cash equivalents 7.13 ­103.1 ­220.0 Cash and cash equivalents at 1 January 219.9 439.9 Cash and cash equivalents as at 31 December 7.13 116.8 219.9 of which held-for-sale cash and cash equivalents as at 31 December 127.0 ­ of which cash and cash equivalents not held for sale on 31 December ­10.2 219.9 Values of previous year adjusted.
RHÖN-KLINIKUM AG Download Center Language
  • English
  • Deutsch